Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
12.50
+0.63 (5.31%)
Jan 16, 2026, 4:00 PM EST - Market closed
Intellia Therapeutics Analyst Ratings
Total Analysts
22
Consensus Rating
Buy
Price Target
$19.83
Upside
+58.64%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wolfe Research | Wolfe Research | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2025 |
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 11, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $17 → $8 | Buy → Hold | Downgrades | $17 → $8 | -36.00% | Nov 11, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $25 → $14 | Strong Buy | Reiterates | $25 → $14 | +12.00% | Nov 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +20.00% | Nov 10, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $48 → $26 | Strong Buy | Maintains | $48 → $26 | +108.00% | Nov 7, 2025 |
| RBC Capital | RBC Capital | Hold Maintains $14 → $9 | Hold | Maintains | $14 → $9 | -28.00% | Nov 7, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $17 → $12 | Hold | Maintains | $17 → $12 | -4.00% | Nov 7, 2025 |
| Barclays | Barclays | Buy Maintains $24 → $14 | Buy | Maintains | $24 → $14 | +12.00% | Nov 7, 2025 |
| Wedbush | Wedbush | Hold Maintains $9 → $7 | Hold | Maintains | $9 → $7 | -44.00% | Nov 7, 2025 |
| Citizens | Citizens | Buy Maintains $29 → $21 | Buy | Maintains | $29 → $21 | +68.00% | Nov 7, 2025 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades $12 → $5 | Hold → Sell | Downgrades | $12 → $5 | -60.00% | Nov 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $18 | Strong Buy | Maintains | $25 → $18 | +44.00% | Oct 30, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $45 → $17 | Buy → Hold | Downgrades | $45 → $17 | +36.00% | Oct 28, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $33 → $29 | Buy | Maintains | $33 → $29 | +132.00% | Oct 28, 2025 |
| Barclays | Barclays | Buy Maintains $26 → $24 | Buy | Maintains | $26 → $24 | +92.00% | Oct 28, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.